SCHEMBL31662940

SCHEMBL31662940

C#CC1CCN(Cc2nc(C)c3ccccc3n2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 7/20 0.40
DRD2 P14416 4/20 0.40
DRD4 P21917 4/20 0.40
DRD3 P35462 4/20 0.40
GRM2 Q14416 2/20 0.40
NCF1 P14598 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
NUDT1 P36639 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CHRM1 P11229 4/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
NTSR1 P30989 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ACHE P22303 1/20 0.37
GPR3 P46089 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663078 0.85 GPR119 (0.43) CHRM1LMNAMAPTCHRM3
SCHEMBL31663310 0.83 MAPT (0.43) DRD2DRD4DRD3GRM2NCF1
SCHEMBL31663067 0.82 DPP4 (0.37) DPP4DRD2DRD4DRD3GRM2
SCHEMBL31663271 0.81 DPP4 (0.41) DPP4CHRM1FAPPOU2F2ADORA3
SCHEMBL31663327 0.74 CYP2C9 (0.41) ALDH1A1CYP1A2HPGDHSD17B10LMNA
SCHEMBL31663115 0.74 OGA (0.36) DPP4DRD2DRD4DRD3ALDH1A1
SCHEMBL31662619 0.73 ALDH1A1 (0.57) DPP4ALDH1A1HPGDMAPTHTT
SCHEMBL31662944 0.73 OGA (0.37) DPP4ALDH1A1CHRM1MAPTHTT
SCHEMBL4767323 0.73 ACHE (0.61) DRD2DRD4DRD3ALDH1A1KMT2A
SCHEMBL31662766 0.72 TUBB4A (0.36) DPP4DRD2DRD4DRD3GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025149628-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE ASTRAZENECA AB (SE) 2025-07-17 WO disclosed